{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:55:57Z","timestamp":1783025757567,"version":"3.54.6"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,13]]},"DOI":"10.7759\/cureus.94442","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:20:22Z","timestamp":1760347222000},"source":"Crossref","is-referenced-by-count":1,"title":["Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes"],"prefix":"10.7759","author":[{"given":"Diogo","family":"Pinto da Costa Viana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Henrique","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Lobo de Souza Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"da Maia Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Comin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Testosterone insufficiency and treatment in women: international expert consensus","author":"Donovitz G","year":"2019","unstructured":"Donovitz G, Schwartz E, Miller C, et al.. Testosterone insufficiency and treatment in women: international expert consensus. Medicina y Salud P\u00fablica, 2019."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.63932\/3067-7106.1015","article-title":"Testosterone: the forgotten female hormone","volume":"1","author":"Horner KA","year":"2025","unstructured":"Horner KA. Testosterone: the forgotten female hormone. Lynchburg J Med Sci. 2025, 1:1-31. 10.63932\/3067-7106.1015","journal-title":"Lynchburg J Med Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00284-3","article-title":"Testosterone in women\u2014the clinical significance","volume":"3","author":"Davis SR","year":"2015","unstructured":"Davis SR, Wahlin-Jacobsen S. Testosterone in women\u2014the clinical significance. Lancet Diabetes Endocrinol. 2015, 3:980-92. 10.1016\/S2213-8587(15)00284-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2013.801736","article-title":"Androgen therapy in women, beyond libido","volume":"16","author":"Davis SR","year":"2013","unstructured":"Davis SR. Androgen therapy in women, beyond libido. Climacteric. 2013, 16:18-24. 10.3109\/13697137.2013.801736","journal-title":"Climacteric"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-01603","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"104","author":"Davis SR","year":"2019","unstructured":"Davis SR, Baber R, Panay N, et al.. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019, 104:4660-6. 10.1210\/jc.2019-01603","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/2053369120957514","article-title":"The British Menopause Society & Women\u2019s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women","volume":"26","author":"Hamoda H","year":"2020","unstructured":"Hamoda H, Panay N, Pedder H, Arya R, Savvas M. The British Menopause Society & Women\u2019s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reprod Health. 2020, 26:181-209. 10.1177\/2053369120957514","journal-title":"Post Reprod Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101783","article-title":"Androgen-based therapies in women","volume":"38","author":"Whitton K","year":"2024","unstructured":"Whitton K, Baber R. Androgen-based therapies in women. Best Pract Res Clin Endocrinol Metab. 2024, 38:101783. 10.1016\/j.beem.2023.101783","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12081194","article-title":"A personal prospective on testosterone therapy in women\u2014what we know in 2022","volume":"12","author":"Donovitz GS","year":"2022","unstructured":"Donovitz GS. A personal prospective on testosterone therapy in women\u2014what we know in 2022. J Pers Med. 2022, 12:1194. 10.3390\/jpm12081194","journal-title":"J Pers Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.11.5280","article-title":"Which androgen replacement therapy for women?","volume":"83","author":"Buckler HM","year":"1998","unstructured":"Buckler HM, Robertson WR, Wu FC. Which androgen replacement therapy for women?. J Clin Endocrinol Metab. 1998, 83:3920-4. 10.1210\/jcem.83.11.5280","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20250121","article-title":"Compounded hormonal pellets: a critical review of current evidence and risks","volume":"71","author":"Wender MC","year":"2025","unstructured":"Wender MC, Steiner ML, Fernandes CE, et al.. Compounded hormonal pellets: a critical review of current evidence and risks. Rev Assoc Med Bras (1992). 2025, 71:e20250121. 10.1590\/1806-9282.20250121","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21037\/tau-2025-51","article-title":"Long-term testosterone pellet insertion in women with low libido shows no evidence of erythrocytosis and a minimal side effect profile","volume":"14","author":"Hernandez BS","year":"2025","unstructured":"Hernandez BS, Saffati G, Lowrey KA, et al.. Long-term testosterone pellet insertion in women with low libido shows no evidence of erythrocytosis and a minimal side effect profile. Transl Androl Urol. 2025, 14:1842-8. 10.21037\/tau-2025-51","journal-title":"Transl Androl Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/og9.0000000000000053","article-title":"Psychiatric manifestations in a postmenopausal woman caused by prolonged testosterone pellet therapy","volume":"1","author":"Daram N","year":"2024","unstructured":"Daram N, Wilhoite M, Hurley E, Kaplan M. Psychiatric manifestations in a postmenopausal woman caused by prolonged testosterone pellet therapy. O G Open. 2024, 1:53. 10.1097\/og9.0000000000000053","journal-title":"O G Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2012.11.004","article-title":"Testosterone implants in women: pharmacological dosing for a physiologic effect","volume":"74","author":"Glaser R","year":"2013","unstructured":"Glaser R, Kalantaridou S, Dimitrakakis C. Testosterone implants in women: pharmacological dosing for a physiologic effect. Maturitas. 2013, 74:179-84. 10.1016\/j.maturitas.2012.11.004","journal-title":"Maturitas"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1981.tb01008.x","article-title":"Hormonal profiles in postmenopausal women after therapy with subcutaneous implants","volume":"88","author":"Thom MH","year":"1981","unstructured":"Thom MH, Collins WP, Studd JW. Hormonal profiles in postmenopausal women after therapy with subcutaneous implants. Br J Obstet Gynaecol. 1981, 88:426-33. 10.1111\/j.1471-0528.1981.tb01008.x","journal-title":"Br J Obstet Gynaecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7292(82)90199-0","article-title":"Endocrine and clinical effects of estradiol and testosterone pellets used in long\u2010term replacement therapy","volume":"20","author":"Kapetanakis E","year":"1982","unstructured":"Kapetanakis E, Dmowski WP, Auletta F, et al.. Endocrine and clinical effects of estradiol and testosterone pellets used in long\u2010term replacement therapy. Int J Gynaecol Obstet. 1982, 20:387-99. 10.1016\/0020-7292(82)90199-0","journal-title":"Int J Gynaecol Obstet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2260","article-title":"Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline","volume":"99","author":"Wierman ME","year":"2014","unstructured":"Wierman ME, Arlt W, Basson R, et al.. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014, 99:3489-510. 10.1210\/jc.2014-2260","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/sexmed\/qfad007","article-title":"Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial","volume":"11","author":"Kresch E","year":"2023","unstructured":"Kresch E, Lima TF, Molina M, et al.. Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial. Sex Med. 2023, 11:qfad007. 10.1093\/sexmed\/qfad007","journal-title":"Sex Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(19)30665-2","article-title":"Formulations and use of androgens in women","volume":"79","author":"Chu MC","year":"2004","unstructured":"Chu MC, Lobo RA. Formulations and use of androgens in women. Mayo Clin Proc. 2004, 79:3-7. 10.1016\/S0025-6196(19)30665-2","journal-title":"Mayo Clin Proc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/js.2017-00148","article-title":"Serum testosterone concentrations remain stable between injections in patients receiving subcutaneous testosterone","volume":"1","author":"McFarland J","year":"2017","unstructured":"McFarland J, Craig W, Clarke NJ, Spratt DI. Serum testosterone concentrations remain stable between injections in patients receiving subcutaneous testosterone. J Endocr Soc. 2017, 1:1095-103. 10.1210\/js.2017-00148","journal-title":"J Endocr Soc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1640","article-title":"Pharmacokinetics of a testosterone gel in healthy postmenopausal women","volume":"91","author":"Singh AB","year":"2006","unstructured":"Singh AB, Lee ML, Sinha-Hikim I, et al.. Pharmacokinetics of a testosterone gel in healthy postmenopausal women. J Clin Endocrinol Metab. 2006, 91:136-44. 10.1210\/jc.2005-1640","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004666","article-title":"Testosterone therapy in women: a clinical challenge","volume":"139","author":"Dorr B","year":"2022","unstructured":"Dorr B, Watson D, Castillo P. Testosterone therapy in women: a clinical challenge. Obstet Gynecol. 2022, 139:342. 10.1097\/AOG.0000000000004666","journal-title":"Obstet Gynecol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-72185-4_12","article-title":"Clinical pharmacology of testosterone pellet implants","author":"Handelsman DJ","year":"1998","unstructured":"Handelsman DJ. Clinical pharmacology of testosterone pellet implants. Testosterone. Nieschlag E, Behre HM (ed): Springer, Berlin, Heidelberg; 1998. 10.1007\/978-3-642-72185-4_12"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30189-5","article-title":"Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data","volume":"7","author":"Islam RM","year":"2019","unstructured":"Islam RM, Bell RJ, Green S, et al.. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019, 7:754-66. 10.1016\/S2213-8587(19)30189-5","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(94)00898-H","article-title":"Testosterone enhances estradiol\u2019s effects on postmenopausal bone density and sexuality","volume":"21","author":"Davis SR","year":"1995","unstructured":"Davis SR, McCloud P, Strauss BJG, et al.. Testosterone enhances estradiol\u2019s effects on postmenopausal bone density and sexuality. Maturitas. 1995, 21:227-36. 10.1016\/0378-5122(94)00898-H","journal-title":"Maturitas"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2010.12.001","article-title":"Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS)","volume":"68","author":"Glaser R","year":"2011","unstructured":"Glaser R, York AE, Dimitrakakis C. Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS). Maturitas. 2011, 68:355-61. 10.1016\/j.maturitas.2010.12.001","journal-title":"Maturitas"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(84)90008-2","article-title":"The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results","volume":"6","author":"Burger HG","year":"1984","unstructured":"Burger HG, Hailes J, Menelaus M, et al.. The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas. 1984, 6:351-8. 10.1016\/0378-5122(84)90008-2","journal-title":"Maturitas"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2012.01.006","article-title":"Testosterone pellet implants and migraine headaches: a pilot study","volume":"71","author":"Glaser R","year":"2012","unstructured":"Glaser R, Dimitrakakis C, Trimble N, Martin V. Testosterone pellet implants and migraine headaches: a pilot study. Maturitas. 2012, 71:385-8. 10.1016\/j.maturitas.2012.01.006","journal-title":"Maturitas"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90183-1","article-title":"Subcutaneous hormone implants for the control of climacteric symptoms","volume":"323","author":"Brincat M","year":"1984","unstructured":"Brincat M, Studd JW, O\u2019Dowd T, et al.. Subcutaneous hormone implants for the control of climacteric symptoms. Lancet. 1984, 323:16-8. 10.1016\/S0140-6736(84)90183-1","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)92026-5","article-title":"Effect of oestrogen and testosterone implants on psychological disorders in the climacteric","volume":"329","author":"Montgomery JC","year":"1987","unstructured":"Montgomery JC, Brincat M, Tapp A, et al.. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet. 1987, 329:297-9. 10.1016\/S0140-6736(87)92026-5","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2008.11.001","article-title":"Study of adverse outcomes in women using testosterone therapy","volume":"62","author":"van Staa TP","year":"2009","unstructured":"van Staa TP, Sprafka JM. Study of adverse outcomes in women using testosterone therapy. Maturitas. 2009, 62:76-80. 10.1016\/j.maturitas.2008.11.001","journal-title":"Maturitas"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000398","article-title":"Gender-affirming hormone therapy for transgender men","volume":"61","author":"Moravek MB","year":"2018","unstructured":"Moravek MB. Gender-affirming hormone therapy for transgender men. Clin Obstet Gynecol. 2018, 61:687-704. 10.1097\/GRF.0000000000000398","journal-title":"Clin Obstet Gynecol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.07.1206","article-title":"Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men","volume":"116","author":"Pirtea P","year":"2021","unstructured":"Pirtea P, Ayoubi JM, Desmedt S, T'Sjoen G. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men. Fertil Steril. 2021, 116:936-42. 10.1016\/j.fertnstert.2021.07.1206","journal-title":"Fertil Steril"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4274\/ejbh.galenos.2021.6213","article-title":"Breast cancer incidence reduction in women treated with subcutaneous testosterone: testosterone therapy and breast cancer incidence study","volume":"17","author":"Donovitz G","year":"2021","unstructured":"Donovitz G, Cotten M. Breast cancer incidence reduction in women treated with subcutaneous testosterone: testosterone therapy and breast cancer incidence study. Eur J Breast Health. 2021, 17:150-6. 10.4274\/ejbh.galenos.2021.6213","journal-title":"Eur J Breast Health"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.294.6577.936","article-title":"Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women","volume":"294","author":"Burger H","year":"1987","unstructured":"Burger H, Hailes J, Nelson J, Menelaus M. Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women. Br Med J (Clin Res Ed). 1987, 294:936-7. 10.1136\/bmj.294.6577.936","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1080\/09513590701550064","article-title":"Effects of subdermal implants of estradiol and testosterone on the endometrium of postmenopausal women","volume":"23","author":"Filho AM","year":"2007","unstructured":"Filho AM, Barbosa IC, Maia H Jr, Genes CC, Coutinho EM. Effects of subdermal implants of estradiol and testosterone on the endometrium of postmenopausal women. Gynecol Endocrinol. 2007, 23:511-7. 10.1080\/09513590701550064","journal-title":"Gynecol Endocrinol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6457-8","article-title":"Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study","volume":"19","author":"Glaser RL","year":"2019","unstructured":"Glaser RL, York AE, Dimitrakakis C. Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study. BMC Cancer. 2019, 19:1271. 10.1186\/s12885-019-6457-8","journal-title":"BMC Cancer"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-1-216","article-title":"Pharmacokinetics and pharmacodynamics of testosterone pellets in man","volume":"71","author":"Handelsman DJ","year":"1990","unstructured":"Handelsman DJ, Conway AJ, Boylan LM. Pharmacokinetics and pharmacodynamics of testosterone pellets in man. J Clin Endocrinol Metab. 1990, 71:216-22. 10.1210\/jcem-71-1-216","journal-title":"J Clin Endocrinol Metab"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707302","article-title":"Testosterone for low libido in postmenopausal women not taking estrogen","volume":"359","author":"Davis SR","year":"2008","unstructured":"Davis SR, Moreau M, Kroll R, et al.. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med. 2008, 359:2005-17. 10.1056\/NEJMoa0707302","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/416645-testosterone-pellets-in-women-revisiting-safety-and-clinical-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:20:23Z","timestamp":1760347223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/416645-testosterone-pellets-in-women-revisiting-safety-and-clinical-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.94442","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}